OpenAlex
Works that cite this article, indexed by OpenAlex.
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies
International Journal of Infectious Diseases 120 (2022)
Dang The Hung; Suhaib Ghula; Jeza Muhamad Abdul Aziz; Abdelrahman M Makram; Gehad Mohamed Tawfik; Ali Ahmed‐Fouad Abozaid; Rohan Andrew Pancharatnam; Amr Mohamed Ibrahim; Muhammad Besher Shabouk; Morgan Turnage; Saloni Nakhare; Zahra Karmally; Basel Kouz; Tran Le; Suleiman Alhijazeen; Nguyen Quoc Phuong; Alaa Mohamed Ads; Ali Hussein Abdelaal; Nguyen Hai Nam; Tatsuo Iiyama; Kyoshi Kita; Kenji Hirayama; Nguyen Tien Huy
Favipiravir for treating COVID-19
Cochrane Database of Systematic Reviews 2024(2) (2024)
Pritish John Korula; Hanna Alexander; Jisha Sara John; Richard Kirubakaran; Bhagteshwar Singh; Prathap Tharyan; Priscilla Rupali
Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
Frontiers in Pharmacology 13 (2022)
Xichuan Li; Wanting “Lisa” Wang; Suying Yan; Weipeng Zhao; Hui Xiong; Cuiping Bao; Jinqian Chen; Yuan Yue; Yanjun Su; Chunze Zhang
Advancements in Antiviral Therapy: Favipiravir Sodium in Nasal Formulation
AAPS PharmSciTech 25(8) (2024)
Priti A. Darne; Shankar Vidhate; Somesh S Shintre; Somnath Wagdare; Dhiraj Bhamare; Nisha Mehta; Vishal Rajagopalan; Sriram Padmanabhan
In-hospital mortality outcomes of favipiravir in patients with moderate to severe COVID-19 infection: An emulated target trial using real-world data from the largest field hospital in Thailand
PLoS ONE 20(6) (2025)
Lalita Lumkul; Krittai Tanasombatkul; Phongsak Nitikaroon; Thotsaporn Morasert; Phichayut Phinyo